ACT-AD

Participant Duration
Participation in the study takes about eight months including approximately six months of treatment duration
State of study
New South Wales
Western Australia
Victoria
Overview

The ACT-AD trial is evaluating if a new investigational drug (ATH-1017) is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease. ATH-1017 is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function. ATH-1017 represents a new approach to treat Alzheimer’s disease, potentially targeting the root cause of memory decline by repairing brain cells and rebuilding brain networks.

You or someone you know may be eligible if you:

  • Are between 55 and 85 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a reliable support person or caregiver who is willing to participate in study visits, report on daily activities and oversee or help you with taking ATH-1017

Study participation and study drug are free to all participants enrolled in the study. You may receive a stipend to compensate for time and effort for study participation including meals, travel, etc.

Further information

To learn more please visit our website: https://www.act-adtrial.com/
For further information, please contact the Clinical Trial Assistant Stephanie Mizuno at +1 425-620-8559, or email at [email protected]

This study received ethical approval from the St. Vincent's Human Research Ethics Committee (Project ID Number: 67363)

Study Address
HammondCare
261 Wattletree Road, Suite 4
Malvern, VIC 3144
Dr. Stephen MacFarlane

Peninsula Therapeutic & Research Group Pty Ltd
137 Frankston-Flinders Road
Frankston, VIC 3199
Dr. Jennifer Grunfeld

Central Coast Neurosciences Research
Suite 4, Level 1 Mingara Health
7 Mingara Drive
Tumbi Umbi, NSW 2261
Dr. Jonathan Sturm

HammondCare Greenwich Hospital
97-115 River Road
Greenwich, NSW 2065
Dr. Mark Hohenberg

KaRa MINDS
35-41 Waterloo Road
Building 3 Suite 1.06
Macquarie Park, NSW 2113
Dr. Rosalyn Lai

St Vincent's Centre for Applied Medical Research, Translational Research Centre
97-105 Boundary Street
Darlinghurst, NSW 2010
Dr. Bruce Brew

Australian Alzheimer's Research Organization
95 Monash Avenue
Hollywood Specialist Centre, Suite 17
Nedlands, WA 6009
Dr. Roger Clarnette
Full Name
Stephanie Mizuno
Institute
Athira Pharma, Inc.
Phone Number
+1 425 620 8559